S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
Log in

NASDAQ:HALOHalozyme Therapeutics SEC Filings & 10K Form

$17.98
+0.29 (+1.64 %)
(As of 04/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.46
Now: $17.98
$18.32
50-Day Range
$13.88
MA: $18.22
$21.83
52-Week Range
$12.71
Now: $17.98
$22.06
Volume939,040 shs
Average Volume1.83 million shs
Market Capitalization$2.48 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.71

SEC Filings

Halozyme Therapeutics (NASDAQ:HALO) SEC Filings

DateFilerForm TypeView
04/09/2020
8:42 AM
Artisan Partners Limited Partnership (Filed by)
Halozyme Therapeutics (Subject)
Form SC 13G
04/03/2020
7:03 AM
Halozyme Therapeutics (Filer)
Form DEFA14A
03/19/2020
6:28 PM
Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
7:04 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
7:03 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
7:02 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
3:16 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
3:15 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
5:41 PM
Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
5:39 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
5:38 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
5:24 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
5:05 PM
Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
5:03 PM
Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
4:59 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
4:56 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
1:24 PM
Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/10/2020
12:41 PM
Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/04/2020
3:11 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/28/2020
8:56 AM
Halozyme Therapeutics (Subject)
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by)
Form SC 13G/A
01/16/2020
3:25 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
3:23 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
4:02 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
5:06 AM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
3:15 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
3:53 PM
Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
Form SC 13D/A
11/05/2019
3:36 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
6:10 PM
Halozyme Therapeutics (Issuer)
Hickey Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
10:20 AM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
3:18 PM
Halozyme Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
7:11 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:01 PM
Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
Form SC 13D/A
06/17/2019
7:19 AM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
12:40 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
4:10 PM
Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
Form SC 13D/A
06/03/2019
4:22 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
4:10 PM
Halozyme Therapeutics (Filer)
Form S-8 POS
05/07/2019
3:08 PM
Halozyme Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2019
3:01 PM
Armour Alison A. (Reporting)
Halozyme Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/03/2019
4:05 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
3:23 PM
Halozyme Therapeutics (Issuer)
Posard Matthew L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
3:20 PM
Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
3:12 PM
Daly James M (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
3:10 PM
Connaughton Bernadette (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2019
3:08 PM
Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
3:07 PM
Halozyme Therapeutics (Filer)
Form DEF 14A
02/22/2019
6:04 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
6:03 PM
Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
6:03 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
6:02 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
3:16 PM
Halozyme Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2019
3:04 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2019
7:10 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 4/A
02/15/2019
4:36 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
4:34 PM
Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
4:33 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
4:32 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
5:29 PM
Halozyme Therapeutics (Issuer)
Hickey Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
5:28 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
5:26 PM
Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
5:24 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
5:22 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
2:48 PM
BB BIOTECH AG (Filed by)
Halozyme Therapeutics (Subject)
Form SC 13G/A
02/11/2019
1:00 PM
Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/06/2019
5:02 PM
Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
1:21 PM
Halozyme Therapeutics (Subject)
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by)
Form SC 13G/A
02/05/2019
3:12 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
3:11 PM
Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
3:10 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
4:04 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2018
3:26 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
3:19 PM
Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2018
4:00 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
3:14 PM
Halozyme Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
3:08 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2018
3:10 PM
Halozyme Therapeutics (Issuer)
Hickey Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
3:17 PM
Halozyme Therapeutics (Issuer)
Hickey Benjamin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2018
5:24 PM
Connaughton Bernadette (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2018
5:21 PM
Connaughton Bernadette (Reporting)
Halozyme Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2018
8:01 AM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
5:06 AM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2018
4:25 PM
Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2018
4:23 PM
Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
Form SC 13D/A
08/23/2018
3:33 PM
Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
4:19 PM
Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
Form SC 13D/A
08/16/2018
4:16 PM
Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2018
4:00 PM
Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2018
3:29 PM
Halozyme Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2018
3:24 PM
Halozyme Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
5:58 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2018
3:35 PM
Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2018
8:55 PM
Halozyme Therapeutics (Issuer)
KIRK RANDAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:23 PM
Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:06 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
4:19 PM
Halozyme Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/10/2018
3:37 PM
Halozyme Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2018
4:09 PM
Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/02/2018
6:42 PM
Halozyme Therapeutics (Issuer)
Posard Matthew L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2018
6:42 PM
Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2018
6:41 PM
Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 4/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel